{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:29:15Z","timestamp":1773034155209,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.vaccine.2009.07.021","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T14:46:14Z","timestamp":1248965174000},"page":"5661-5666","source":"Crossref","is-referenced-by-count":19,"title":["Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D"],"prefix":"10.1016","volume":"27","author":[{"given":"Christina","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Mazuet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.07.021_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.021_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1024\/0036-7281.148.10.553","article-title":"Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland?","volume":"148","author":"Gerber","year":"2006","journal-title":"Schweiz Arch Tierheilkd"},{"key":"10.1016\/j.vaccine.2009.07.021_bib3","first-page":"32","article-title":"Zoonosebericht 2002","volume":"3","author":"Botulismus","year":"2003","journal-title":"BVET-Magazin"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.021_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0749-0739(17)30053-6","article-title":"Botulism in the horse","volume":"17","author":"Galey","year":"2001","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.07.021_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.vetmic.2008.02.003","article-title":"Tonsils\u2014place of botulinum toxin production: results of routine laboratory diagnosis in farm animals","volume":"130","author":"B\u00f6hnel","year":"2008","journal-title":"Vet Microbiol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.07.021_bib6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.021_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, present, and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.021_bib8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.021_bib9","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.021_bib10","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.021_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1348-0421.2007.tb03919.x","article-title":"C terminal half fragment (50kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine","volume":"51","author":"Lee","year":"2007","journal-title":"Microbiol Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.07.021_bib12","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.71.5.2941-2944.2003","article-title":"Expression of HC subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice","volume":"71","author":"Woodward","year":"2003","journal-title":"Infect Immun"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2009.07.021_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CDLI.11.3.496-502.2004","article-title":"Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum type C and D neurotoxins","volume":"11","author":"Arimitsu","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2009.07.021_bib14","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.021_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2746\/042516407X236550","article-title":"Alternative vaccination against equine botulism (BoNT\/C)","volume":"39","author":"Frey","year":"2007","journal-title":"Equine Vet J"},{"issue":"16","key":"10.1016\/j.vaccine.2009.07.021_bib16","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1093\/nar\/18.16.4924","article-title":"Nucleotide sequence of Clostridium botulinum C1 neurotoxin","volume":"18","author":"Hauser","year":"1990","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"10.1016\/j.vaccine.2009.07.021_bib17","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1093\/nar\/18.18.5556","article-title":"Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D","volume":"18","author":"Binz","year":"1990","journal-title":"Nucleic Acids Res"},{"issue":"1-3","key":"10.1016\/j.vaccine.2009.07.021_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2009.07.021_bib19","unstructured":"European Pharmacopoeia. Botulinum antitoxin. 4th edition; 2002. p. 0085."},{"key":"10.1016\/j.vaccine.2009.07.021_bib20","series-title":"Handbook for epidemiologists, clinicians, and laboratory workers","author":"Centers for Disease Control and Prevention: Botulism in the U.S. and Canada, 1899\u20131996","year":"1998"},{"key":"10.1016\/j.vaccine.2009.07.021_bib21","first-page":"65","article-title":"The immunization of bovines against lamsiekte","volume":"9","author":"Mason","year":"1938","journal-title":"J S Afr Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.021_bib22","first-page":"165","article-title":"The antibody response of cattle to Clostridium botulinum types C and D toxoids","volume":"43","author":"Jansen","year":"1976","journal-title":"Onderstepoort J Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.021_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1751-0813.1996.tb09966.x","article-title":"Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle","volume":"73","author":"Gregory","year":"1996","journal-title":"Aust Vet J"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.021_bib24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/CVI.00046-06","article-title":"Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism","volume":"13","author":"Steinman","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.07.021_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2746\/042516401776563418","article-title":"Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)?","volume":"33","author":"Hunter","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2009.07.021_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum IX: immunologic response of man to purified pentavalent ABCDE botulinum toxoid","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"issue":"November (44)","key":"10.1016\/j.vaccine.2009.07.021_bib27","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1016\/j.vaccine.2007.08.051","article-title":"Cattle immune response to botulinum type D toxoid: results of a vaccination study","volume":"25","author":"Steinman","year":"2007","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.07.021_bib28","first-page":"728","article-title":"The immunogenicity in humans of a botulinum type F vaccine","volume":"18","author":"Montgomery","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.07.021_bib29","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1128\/JCM.26.11.2351-2356.1988","article-title":"Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay","volume":"26","author":"Siegel","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.021_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1045-1056(02)00074-X","article-title":"Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates","volume":"31","author":"Lindsey","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.07.021_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.88.3.277","article-title":"Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid","volume":"88","author":"Fiock","year":"1962","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:44:35Z","timestamp":1685079875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":31,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0264410X09010251"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}